Why meperidine should not make a comeback in treating patients with sickle cell disease.
Howland
Mary Ann
MA
St. John's University College of Pharmacy, New York University School of Medicine, New York City Poison Control Center, Bellevue Hospital's Emergency Department, Queens, NY, USA. MHowlandNY@aol.com
Goldfrank
Lewis R
LR
D000701:Analgesics, Opioid / Q000378:metabolism / Q000627:therapeutic use*; D000755:Anemia, Sickle Cell / Q000150:complications*; D006801:Humans; D008614:Meperidine / Q000378:metabolism / Q000627:therapeutic use*; D010146:Pain / Q000209:etiology / Q000517:prevention & control*
D000701:Analgesics, Opioid; D008614:Meperidine